teriflunomide mylan
mylan pharmaceuticals limited - teriflunomide - la esclerosis múltiple remitente-recurrente - inmunosupresores - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
teriflunomide accord
accord healthcare s.l.u. - teriflunomide - la esclerosis múltiple remitente-recurrente - los inmunosupresores selectivos de inmunosupresores - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
teriflunomida sandoz 14 mg comprimidos recubiertos con pelicula efg
sandoz farmaceutica s.a. - teriflunomida - comprimido recubierto con pelÍcula - 14 mg - teriflunomida 14 mg - teriflunomida
teriflunomida dr reddys 14 mg comprimidos recubiertos con pelicula efg
reddy pharma iberia s.a. - teriflunomida - comprimido recubierto con pelÍcula - 14 mg - teriflunomida 14 mg - teriflunomida
teriflunomida teva 14 mg comprimidos recubiertos con pelicula efg
teva b.v. - teriflunomida - comprimido recubierto con pelÍcula - 14 mg - teriflunomida 14 mg - teriflunomida
prolia 60 mg 1 xeringa precarregada 1 ml
synjardy 12,5/1000 mg 60 comprimidos recubiertos
synjardy 5/1000 mg 60 comprimidos recubiertos
principi actiu: teriflunomida
brintellix 5 mg 28 comprimits recoberts